ZEPP Zepp Health Corporation
Technology$8.80+2.09%ClosedMarket Cap: $126.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.04
P/S
0.45
EV/EBITDA
-8.78
DCF Value
$-149.81
FCF Yield
-3.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
38.5%
Operating Margin
-11.4%
Net Margin
-15.6%
ROE
-17.9%
ROA
-7.3%
ROIC
-6.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $598.1M | 41.0% | $-27.2M | $-77.1M | $— | — |
| FY null | $1.82B | 39.2% | $-204.9M | $-280.9M | $— | — |
| Q3 null | $539.6M | 38.2% | $-6.3M | $-11.5M | $— | — |
| Q2 null | $427.1M | 36.2% | $-43.9M | $-55.6M | $— | — |
| Q1 null | $279.9M | 37.3% | $-133.5M | $-143.4M | $— | — |
| Q4 null | $433.0M | 36.8% | $-65.0M | $-268.6M | $— | — |
| FY null | $1.33B | 38.5% | $-345.0M | $-554.1M | $— | — |
| Q3 null | $297.7M | 40.6% | $-87.9M | $-92.9M | $— | — |
| Q2 null | $295.3M | 40.3% | $-71.7M | $-78.7M | $— | — |
| Q1 null | $288.9M | 36.8% | $-115.0M | $-106.8M | $— | — |
| Q4 2023 | $592.1M | 34.7% | $4.5M | $-9.1M | $-0.07 | — |
| FY null | $2.50B | 26.2% | $-215.5M | $-220.5M | $— | — |